InsidersTradesSigma
PHARMANUTRA INTERIM MANAGMENT REPORT AS OF 30 SEPTEMBER 2023 Stock: price and insider trades · Italy · Consob
Track the PHARMANUTRA INTERIM MANAGMENT REPORT AS OF 30 SEPTEMBER 2023 stock price and the full insider trade history of the company, a publicly traded company based in Italy. Shares trade on IT IT, under the supervision of Consob. Operating in the Health Care sector, PHARMANUTRA INTERIM MANAGMENT REPORT AS OF 30 SEPTEMBER 2023 has recorded 1 public disclosures. Market capitalisation: €861.8m. The latest transaction was filed on 10 November 2023 (Other). Among the most active insiders: Unknown. All data is openly available.
1
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate PHARMANUTRA INTERIM MANAGMENT REPORT AS OF 30 SEPTEMBER 2023 Strong Buy (bullish), based on 3 analysts. Average price target: €81.33.
Fundamental score
Ranked 8,051 of 26,212 companies
61.1
score / 100
Value37
Quality85
FCF yld1.9%
Earn yld2.3%
EV/EBITDA26.1x
ROE30%
Gross mgn77%
Net mgn15%
Debt/EBITDA0.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 10 November 2023